Mawson Infrastructure Group Inc. Announces Participation in Upcoming Conferences and Events - Mawson Infra Gr ( NASDAQ:MIGI )
MIDLAND, Pa., April 15, 2025 ( GLOBE NEWSWIRE ) -- Mawson Infrastructure Group Inc.
Purpose Investments to Launch World's First Spot Solana ETF
TORONTO, April 15, 2025 ( GLOBE NEWSWIRE ) -- Purpose Investments Inc. ( "Purpose" ) , the firm behind the world's first spot Bitcoin and Ether ETFs, is set to launch the world's first spot Solana ETF - Purpose Solana ETF SOLL. The ETF is expected to commence trading on the Toronto Stock ...
Repligen to Report First Quarter 2025 Financial Results
Webcast and Conference Call to Be Held Tuesday, April 29, 2025, at 8:30 a.m. ET Webcast and Conference Call to Be Held Tuesday, April 29, 2025, at 8:30 a.m. ET ...
Zions Bancorporation to Implement nCino Platform and Intelligent Solutions as the Technology Foundation of its Lending End-to-End Process Transformation
WILMINGTON, N.C., April 15, 2025 ( GLOBE NEWSWIRE ) -- nCino, Inc. ( NASDAQ: NCNO ) , the leading provider of intelligent, best-in-class banking solutions, today announced that Zions Bancorporation has selected nCino as its technology platform as they digitally transform their loan origination ...
A quarter of Gen Z now pays for social media
Paying to post: new data reveals social media has joined Gen Z's growing list of subscriptions - now costing nearly $1,000 a year Paying to post: new data reveals social media has joined Gen Z's growing list of subscriptions - now costing nearly $1,000 a year ...
Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments - Dyne Therapeutics ( NASDAQ:DYN )
- Vikram Ranade, PhD, appointed as chief business officer - - Ranjan Batra, PhD, appointed as chief scientific officer - - Oxana Beskrovnaya, PhD, transitioning to chief innovation officer - WALTHAM, Mass., April 15, 2025 ( GLOBE NEWSWIRE ) -- Dyne Therapeutics, Inc.
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
DURHAM, N.C., April 15, 2025 ( GLOBE NEWSWIRE ) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S.
Tariffs are the mother of all cost shocks
The Fed needs to consider how levies raise prices and what it should do about it ...